Skip to content

Geron GERN Accounts Receivable

Accounts Receivable at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$9.37B-13.3%
Incyte logo
IncyteINCY
$1.05B+27.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$38.12M+142%
Exelixis logo
ExelixisEXEL
$328.95M+16.8%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$836.3M+28.1%
Gilead Sciences logo
Gilead SciencesGILD
$5.54B+5.5%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's accounts receivable?
Geron (GERN) reported accounts receivable of $41.88M in Q1 2026.
How has Geron's accounts receivable changed year-over-year?
Geron's accounts receivable increased by 34.4% year-over-year, from $31.17M to $41.88M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.